Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Experience-Dependent Development and Maintenance of Binocular Neurons in the Mouse Visual Cortex.

Jenks KR, Shepherd JD.

Cell Rep. 2020 Feb 11;30(6):1982-1994.e4. doi: 10.1016/j.celrep.2020.01.031.

PMID:
32049025
2.

Structures of virus-like capsids formed by the Drosophila neuronal Arc proteins.

Erlendsson S, Morado DR, Cullen HB, Feschotte C, Shepherd JD, Briggs JAG.

Nat Neurosci. 2020 Feb;23(2):172-175. doi: 10.1038/s41593-019-0569-y. Epub 2020 Jan 6.

PMID:
31907439
3.

The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling.

Brown DG, Soto R, Yandamuri S, Stone C, Dickey L, Gomes-Neto JC, Pastuzyn ED, Bell R, Petersen C, Buhrke K, Fujinami RS, O'Connell RM, Stephens WZ, Shepherd JD, Lane TE, Round JL.

Elife. 2019 Jul 16;8. pii: e47117. doi: 10.7554/eLife.47117.

4.

Deconstructing the synapse.

Shepherd JD.

Nat Neurosci. 2018 Oct;21(10):1294-1295. doi: 10.1038/s41593-018-0244-8. No abstract available.

PMID:
30250264
5.

Feasibility of Telerehabilitation for Low Vision: Satisfaction Ratings by Providers and Patients.

Bittner AK, Yoshinaga P, Bowers A, Shepherd JD, Succar T, Ross NC.

Optom Vis Sci. 2018 Sep;95(9):865-872. doi: 10.1097/OPX.0000000000001260.

PMID:
30169361
6.

The Temporal Dynamics of Arc Expression Regulate Cognitive Flexibility.

Wall MJ, Collins DR, Chery SL, Allen ZD, Pastuzyn ED, George AJ, Nikolova VD, Moy SS, Philpot BD, Shepherd JD, Müller J, Ehlers MD, Mabb AM, Corrêa SAL.

Neuron. 2018 Jun 27;98(6):1124-1132.e7. doi: 10.1016/j.neuron.2018.05.012. Epub 2018 May 31.

7.

The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer.

Pastuzyn ED, Day CE, Kearns RB, Kyrke-Smith M, Taibi AV, McCormick J, Yoder N, Belnap DM, Erlendsson S, Morado DR, Briggs JAG, Feschotte C, Shepherd JD.

Cell. 2018 Mar 22;173(1):275. doi: 10.1016/j.cell.2018.03.024. No abstract available.

8.

The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer.

Pastuzyn ED, Day CE, Kearns RB, Kyrke-Smith M, Taibi AV, McCormick J, Yoder N, Belnap DM, Erlendsson S, Morado DR, Briggs JAG, Feschotte C, Shepherd JD.

Cell. 2018 Jan 11;172(1-2):275-288.e18. doi: 10.1016/j.cell.2017.12.024. Erratum in: Cell. 2018 Mar 22;173(1):275.

9.

Vision Rehabilitation Preferred Practice Pattern®.

Fontenot JL, Bona MD, Kaleem MA, McLaughlin WM Jr, Morse AR, Schwartz TL, Shepherd JD, Jackson ML; American Academy of Ophthalmology Preferred Practice Pattern Vision Rehabilitation Committee.

Ophthalmology. 2018 Jan;125(1):P228-P278. doi: 10.1016/j.ophtha.2017.09.030. Epub 2017 Nov 4. Review. No abstract available.

PMID:
29108747
10.

Arc - An endogenous neuronal retrovirus?

Shepherd JD.

Semin Cell Dev Biol. 2018 May;77:73-78. doi: 10.1016/j.semcdb.2017.09.029. Epub 2017 Sep 24. Review.

11.

Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.

Pastuzyn ED, Shepherd JD.

Front Mol Neurosci. 2017 Jul 28;10:234. doi: 10.3389/fnmol.2017.00234. eCollection 2017.

12.

Arc restores juvenile plasticity in adult mouse visual cortex.

Jenks KR, Kim T, Pastuzyn ED, Okuno H, Taibi AV, Bito H, Bear MF, Shepherd JD.

Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):9182-9187. doi: 10.1073/pnas.1700866114. Epub 2017 Aug 8.

13.

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.

Moccia AA, Hitz F, Hoskins P, Klasa R, Power MM, Savage KJ, Shenkier T, Shepherd JD, Slack GW, Song KW, Gascoyne RD, Connors JM, Sehn LH.

Leuk Lymphoma. 2017 Feb;58(2):324-332. Epub 2016 Jun 27.

PMID:
27347845
14.

Arc: building a bridge from viruses to memory.

Day C, Shepherd JD.

Biochem J. 2015 Jul 1;469(1):e1-3. doi: 10.1042/BJ20150487.

PMID:
26173260
15.

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.

Sun H, Savage KJ, Karsan A, Slack GW, Gascoyne RD, Toze CL, Sehn LH, Abou Mourad Y, Barnett MJ, Broady RC, Connors JM, Forrest DL, Gerrie AS, Hogge DE, Narayanan S, Nevill TJ, Nantel SH, Power MM, Sutherland HJ, Villa D, Shepherd JD, Song KW.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):341-8. doi: 10.1016/j.clml.2014.12.015. Epub 2015 Jan 3.

PMID:
25656914
16.

Imaging activity in neurons and glia with a Polr2a-based and cre-dependent GCaMP5G-IRES-tdTomato reporter mouse.

Gee JM, Smith NA, Fernandez FR, Economo MN, Brunert D, Rothermel M, Morris SC, Talbot A, Palumbos S, Ichida JM, Shepherd JD, West PJ, Wachowiak M, Capecchi MR, Wilcox KS, White JA, Tvrdik P.

Neuron. 2014 Sep 3;83(5):1058-72. doi: 10.1016/j.neuron.2014.07.024. Epub 2014 Aug 21.

17.

Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.

Gerrie AS, Power MM, Shepherd JD, Savage KJ, Sehn LH, Connors JM.

Ann Oncol. 2014 Nov;25(11):2218-23. doi: 10.1093/annonc/mdu387. Epub 2014 Aug 22.

18.

Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.

Abou Mourad YR, Bhargava R, Bruyère H, Gillian T, Barnett MJ, Forrest DL, Nevill TJ, Toze CL, Nantel SH, Shepherd JD.

Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):281-6. doi: 10.1016/j.clml.2012.09.007. Epub 2012 Oct 24.

PMID:
23098889
19.

SCI-U: e-learning for patient education in spinal cord injury rehabilitation.

Shepherd JD, Badger-Brown KM, Legassic MS, Walia S, Wolfe DL.

J Spinal Cord Med. 2012 Sep;35(5):319-29. doi: 10.1179/2045772312Y.0000000044.

20.

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.

Toze CL, Dalal CB, Nevill TJ, Gillan TL, Abou Mourad YR, Barnett MJ, Broady RC, Forrest DL, Hogge DE, Nantel SH, Power MM, Song KW, Sutherland HJ, Smith CA, Narayanan S, Young SS, Connors JM, Shepherd JD.

Br J Haematol. 2012 Jul;158(2):174-185. doi: 10.1111/j.1365-2141.2012.09170.x. Epub 2012 May 29.

PMID:
22640008
21.

Experimental analysis of perching in the European starling (Sturnus vulgaris: Passeriformes; Passeres), and the automatic perching mechanism of birds.

Galton PM, Shepherd JD.

J Exp Zool A Ecol Genet Physiol. 2012 Apr;317(4):205-15. doi: 10.1002/jez.1714.

PMID:
22539208
22.

Memory, plasticity and sleep - A role for calcium permeable AMPA receptors?

Shepherd JD.

Front Mol Neurosci. 2012 Apr 11;5:49. doi: 10.3389/fnmol.2012.00049. eCollection 2012.

23.

Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.

Tantiworawit A, Power MM, Barnett MJ, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Song KW, Sutherland HJ, Toze CL, Abou-Mourad YR, Narayanan S, Broady RC, Forrest DL.

Leuk Lymphoma. 2012 Jul;53(7):1321-6. doi: 10.3109/10428194.2011.652108. Epub 2012 Mar 5.

PMID:
22192245
24.

Arc/Arg3.1 regulates an endosomal pathway essential for activity-dependent β-amyloid generation.

Wu J, Petralia RS, Kurushima H, Patel H, Jung MY, Volk L, Chowdhury S, Shepherd JD, Dehoff M, Li Y, Kuhl D, Huganir RL, Price DL, Scannevin R, Troncoso JC, Wong PC, Worley PF.

Cell. 2011 Oct 28;147(3):615-28. doi: 10.1016/j.cell.2011.09.036.

25.

New views of Arc, a master regulator of synaptic plasticity.

Shepherd JD, Bear MF.

Nat Neurosci. 2011 Mar;14(3):279-84. doi: 10.1038/nn.2708. Epub 2011 Jan 30. Review.

PMID:
21278731
26.

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).

Venner CP, Connors JM, Sutherland HJ, Shepherd JD, Hamata L, Mourad YA, Barnett MJ, Broady R, Forrest DL, Hogge DE, Nantel SH, Narayanan S, Nevill TJ, Nitta J, Power MM, Toze CL, Smith CA, Song KW.

Leuk Lymphoma. 2011 Jan;52(1):34-41. doi: 10.3109/10428194.2010.531409. Epub 2010 Dec 6.

PMID:
21133716
27.

Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study.

Seftel MD, Paulson K, Doocey R, Song K, Czaykowski P, Coppin C, Forrest D, Hogge D, Kollmansberger C, Smith CA, Shepherd JD, Toze CL, Murray N, Sutherland H, Nantel S, Nevill TJ, Barnett MJ.

Bone Marrow Transplant. 2011 Jun;46(6):852-7. doi: 10.1038/bmt.2010.250. Epub 2010 Nov 1.

PMID:
21042312
28.

SRF binding to SRE 6.9 in the Arc promoter is essential for LTD in cultured Purkinje cells.

Smith-Hicks C, Xiao B, Deng R, Ji Y, Zhao X, Shepherd JD, Posern G, Kuhl D, Huganir RL, Ginty DD, Worley PF, Linden DJ.

Nat Neurosci. 2010 Sep;13(9):1082-9. doi: 10.1038/nn.2611. Epub 2010 Aug 8.

29.

Loss of Arc renders the visual cortex impervious to the effects of sensory experience or deprivation.

McCurry CL, Shepherd JD, Tropea D, Wang KH, Bear MF, Sur M.

Nat Neurosci. 2010 Apr;13(4):450-7. doi: 10.1038/nn.2508. Epub 2010 Mar 14.

30.

Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.

Wright MP, Shepherd JD, Barnett MJ, Nantel SH, Sutherland HJ, Toze CL, Hogge DE, Nevill TJ, Song KW, Abou Mourad YR, Narayanan S, Power MM, Smith CA, Forrest DL.

Biol Blood Marrow Transplant. 2010 May;16(5):639-46. doi: 10.1016/j.bbmt.2009.11.026. Epub 2010 Feb 4.

31.

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.

Abou-Mourad YR, Lau BC, Barnett MJ, Forrest DL, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Smith CA, Song KW, Sutherland HJ, Toze CL, Lavoie JC.

Bone Marrow Transplant. 2010 Feb;45(2):295-302. doi: 10.1038/bmt.2009.128. Epub 2009 Jul 13.

PMID:
19597425
32.

Recurrence of lymphoid blast crisis over 20 years after successful sibling allo-SCT for CML: short lived complete cytogenetic response to imatinib.

Irvine DA, Shepherd JD.

Bone Marrow Transplant. 2009 Aug;44(4):267-8. doi: 10.1038/bmt.2009.11. Epub 2009 Feb 23. No abstract available.

PMID:
19234506
33.

IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.

Nevill TJ, Shepherd JD, Sutherland HJ, Abou Mourad YR, Lavoie JC, Barnett MJ, Nantel SH, Toze CL, Hogge DE, Forrest DL, Song KW, Power MM, Nitta JY, Dai Y, Smith CA.

Biol Blood Marrow Transplant. 2009 Feb;15(2):205-13. doi: 10.1016/j.bbmt.2008.11.015.

34.

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.

Forrest DL, Trainor S, Brinkman RR, Barnett MJ, Hogge DE, Nevill TJ, Shepherd JD, Nantel SH, Toze CL, Sutherland HJ, Song KW, Lavoie JC, Power MM, Abou-Mourad Y, Smith CA.

Leuk Res. 2009 Feb;33(2):271-5. doi: 10.1016/j.leukres.2008.07.015. Epub 2008 Aug 31.

PMID:
18762338
35.

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.

Ramadan KM, Connors JM, Al-Tourah AJ, Song KW, Gascoyne RD, Barnett MJ, Nevill TJ, Shepherd JD, Nantel SH, Sutherland HJ, Forrest DL, Hogge DE, Lavoie JC, Abou-Mourad YR, Chhanabhai M, Voss NJ, Brinkman RR, Smith CA, Toze CL.

Bone Marrow Transplant. 2008 Nov;42(9):601-8. doi: 10.1038/bmt.2008.220. Epub 2008 Aug 11.

PMID:
18695664
36.

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.

Nevill TJ, Hogge DE, Toze CL, Nantel SH, Power MM, Abou Mourad YR, Song KW, Lavoie JC, Forrest DL, Barnett MJ, Shepherd JD, Nitta JY, Wong S, Sutherland HJ, Smith CA.

Bone Marrow Transplant. 2008 Nov;42(10):659-66. doi: 10.1038/bmt.2008.226. Epub 2008 Aug 4.

PMID:
18679372
37.

Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD.

Park S, Park JM, Kim S, Kim JA, Shepherd JD, Smith-Hicks CL, Chowdhury S, Kaufmann W, Kuhl D, Ryazanov AG, Huganir RL, Linden DJ, Worley PF.

Neuron. 2008 Jul 10;59(1):70-83. doi: 10.1016/j.neuron.2008.05.023.

38.

Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.

Kuruvilla J, Shepherd JD, Sutherland HJ, Nevill TJ, Nitta J, Le A, Forrest DL, Hogge DE, Lavoie JC, Nantel SH, Toze CL, Smith CA, Barnett MJ, Song KW.

Biol Blood Marrow Transplant. 2007 Aug;13(8):925-31. Epub 2007 May 29.

39.

The cell biology of synaptic plasticity: AMPA receptor trafficking.

Shepherd JD, Huganir RL.

Annu Rev Cell Dev Biol. 2007;23:613-43. Review.

PMID:
17506699
40.

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.

Halim TY, Song KW, Barnett MJ, Forrest DL, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Smith CA, Sutherland HJ, Toze CL, Lavoie JC.

Ann Oncol. 2007 Jul;18(7):1246-52. Epub 2007 Apr 17.

41.

Rapid mapping and prioritisation of wetland sites in the Manawatu-Wanganui region, New Zealand.

Ausseil AG, Dymond JR, Shepherd JD.

Environ Manage. 2007 Mar;39(3):316-25. Epub 2007 Jan 29.

PMID:
17265113
42.

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.

Song KW, Barnett MJ, Gascoyne RD, Chhanabhai M, Forrest DL, Hogge DE, Lavoie JC, Nantel SH, Nevill TJ, Shepherd JD, Smith CA, Sutherland HJ, Toze CL, Voss NJ, Connors JM.

Ann Oncol. 2007 Mar;18(3):535-40. Epub 2006 Dec 8.

43.

Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors.

Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, Huganir RL, Worley PF.

Neuron. 2006 Nov 9;52(3):475-84.

44.

Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking.

Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, Kuhl D, Huganir RL, Worley PF.

Neuron. 2006 Nov 9;52(3):445-59.

45.

Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.

Lin Y, Bruyère H, Horsman DE, Pantzar T, Barnett MJ, Hogge DE, Nevill TJ, Nantel SH, Sutherland HJ, Toze CL, Shepherd JD, Lavoie JC, Song KW, Smith CA, Forrest DL.

Cancer Genet Cytogenet. 2006 Oct 1;170(1):16-23.

PMID:
16965950
46.

Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma.

Song KW, Barnett MJ, Gascoyne RD, Horsman DE, Forrest DL, Hogge DE, Lavoie JC, Nantel SH, Nevill TJ, Shepherd JD, Smith CA, Sutherland HJ, Voss NJ, Toze CL, Connors JM.

Br J Haematol. 2006 Jun;133(6):634-7.

PMID:
16704438
47.

Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.

Johny A, Song KW, Nantel SH, Lavoie JC, Toze CL, Hogge DE, Forrest DL, Sutherland HJ, Le A, Nitta JY, Barnett MJ, Smith CA, Shepherd JD, Nevill TJ.

Biol Blood Marrow Transplant. 2006 Apr;12(4):480-9.

48.

Shifting to outpatient management of acute myeloid leukemia: a prospective experience.

Savoie ML, Nevil TJ, Song KW, Forrest DL, Hogge DE, Nantel SH, Shepherd JD, Smith CA, Sutherland HJ, Toze CL, Lavoie JC.

Ann Oncol. 2006 May;17(5):763-8. Epub 2006 Feb 23.

49.

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.

Forrest DL, Hogge DE, Nevill TJ, Nantel SH, Barnett MJ, Shepherd JD, Sutherland HJ, Toze CL, Smith CA, Lavoie JC, Song KW, Voss NJ, Gascoyne RD, Connors JM.

J Clin Oncol. 2005 Nov 1;23(31):7994-8002. Epub 2005 Oct 3.

PMID:
16204014
50.

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

Doocey RT, Toze CL, Connors JM, Nevill TJ, Gascoyne RD, Barnett MJ, Forrest DL, Hogge DE, Lavoie JC, Nantel SH, Shepherd JD, Sutherland HJ, Voss NJ, Smith CA, Song KW.

Br J Haematol. 2005 Oct;131(2):223-30.

PMID:
16197454

Supplemental Content

Loading ...
Support Center